Skip to main content

Price-sensitive press releases

2021-05-18
STOCKHOLM, May 18[th], 2021. Moberg Pharma AB (publ)’s (“Moberg Pharma” or the “Company”) Annual General Meeting took place today. The Annual General Meeting resolved in accordance with the Nomination Committee’s and Board of Directors’ proposals as set out below.
2021-05-11
REGISTRATION PREPARATIONS FULLY UNDERWAY 
2021-04-19
Shareholders in Moberg Pharma AB (publ) (reg. no. 556697-7426) (the “Company”) are hereby convened to the Annual General Meeting on Tuesday, 18 May 2021.
2021-02-09
Financing for both MOB-015 and BUPI
2021-02-02
STOCKHOLM, February 2[nd], 2021 - On February 9[th], 2021, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will present its Year-end report for the financial year 2020. Investors, analysts and journalists are hereby invited to participate in a teleconference at 3:00 pm (CET) on the same date.